title: Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
authors.affiliation: Department of Transplantation Immunology, University of Heidelberg, FRG.
authors.forename: I L
authors.initials: IL
authors.lastname: Noronha
authors.forename: V
authors.initials: V
authors.lastname: Daniel
authors.forename: M
authors.initials: M
authors.lastname: Rambausek
authors.forename: R
authors.initials: R
authors.lastname: Waldherr
authors.forename: G
authors.initials: G
authors.lastname: Opelz
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003524:Cyclosporins / Q000009:adverse effects; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*; D014777:Virus Diseases / Q000097:blood / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha